Elizabeth Edgerly

[Elizabeth Edgerly @eedgerly]

.@RepAnnaEshoo please cosponsor the BOLD Reauthorization Act of 2024 (H.R.7218). #ENDALZ

[Alzheimer's Association @alzassociation]

The BOLD Reauthorization Act has been introduced in the House! This critical piece of legislation will build off the success of the #BOLDAlzheimersAct, which empowers public health departments to improve brain health and support caregivers in their communities. https://t.co/rIGd3QAaDL

[Elizabeth Edgerly @eedgerly]

.@SenAlexPadilla @LaphonzaB please cosponsor the BOLD Reauthorization Act of 2024. #ENDALZ

[Elizabeth Edgerly @eedgerly]

I just registered to rally for Access to Alzheimer's treatments in San Francisco. Will you join me? https://t.co/qOvxcpvZPP

[Deb Anderson @weedebs2]

My thank you to @RepAnnaEshoo for her remarks to the CMS Administrator urging him to reserve their stance on FDA approved drugs was published in the Mercury News today. Thank you for your support! #ENDALZ @AlzNorCalNorNev

[Elizabeth Edgerly @eedgerly]

I just registered to rally for Access to Alzheimer's treatments in San Francisco. Will you join me? https://t.co/Sw6BBp8OvQ

[Elizabeth Edgerly @eedgerly]

Please tell CMS to put effective FDA-approved treatments that slow clinical decline into the hands of #Alzheimers patients as quickly as possible. @RepAnnaEshoo @SenAlexPadilla @SenFeinstein #ENDALZ https://t.co/wiwCObdOlx

[Alzheimer's Association @alzassociation]

Thank you, @RepBarragan, for calling out the “failure of @CMSGov to provide meaningful coverage for the class of therapies targeting Alzheimer’s disease” and the concern around this decision from members of Congress on both sides of the aisle. #AccessNow

[ALZ Impact Movement @ALZIMPACT]

“We need to continue to develop evidence and understand the impact of the drug.” No, @BrooksLaSureCMS. It’s the FDA’s job to determine if treatments are safe and effective, not @CMSGov. This decision is unprecedented and robs people with early Alzheimer’s from having #MoreTime.

[ALZ Impact Movement @ALZIMPACT]

Retweet if you stand with people living with early Alzheimer’s who want #AccessNow to FDA-approved treatments! @CMSGov needs to hear from you.

[Alzheimer's Association, Georgia Chapter @AlzGA]

We need #AccessNow! 365 days ago, people living with early Alzheimer’s became the ONLY Americans to be denied access to FDA-approved treatments. Here are 5 important things to know about this decision & why @CMSGov must IMMEDIATELY reverse it: https://t.co/KIcWe9JgzT. #MoreTime

[mendomemories @mendomemories]

⁦@JaredHuffman⁩ please ask @CMSgov why they're treating people with Alzheimer's differently than people with every other fatal disease. #AccessNow #MoreTime ⁦
Local advocates: ‘I’m asking for a little more time’ – The Ukiah Daily Journal https://t.co/QgxSQ51KoZ

[Tony Gonzales @tg101marketing]

Help me get access now! @POTUS you can help us!!! #endalz #moretime #Adelante #live4today

[ALZ Impact Movement @ALZIMPACT]

Retweet to tell @POTUS that @CMSGov must reverse its decision to block access to FDA-approved drugs that could give people with early Alzheimer’s #MoreTime. #AccessNow

[Alzheimer's Association @alzassociation]

Our voices are stronger together! RETWEET if you stand with us against @CMSGov’s decision to block FDA-approved Alzheimer's treatments. People living with early Alzheimer's and their families deserve #MoreTime. #AccessNow

[Elizabeth Edgerly @eedgerly]

I’m proud to represent the Dementia Care Aware initiative at ASA. What a wonderful topic at this morning’s session. How can we lift up the voices of elders… share their wisdom and stories?

[Kate Kriner @k8kriner]

Looking forward to meeting with staff with @KevinKileyCA and sharing the work we are doing for the 790k Californians living with Alzheimer’s and related dementias #AccessNow #endalz @californiaalz @ALZIMPACT

[Kate Kriner @k8kriner]

Thank you Anthony @KevinKileyCA’s office for your time and sharing your own connection to #Alzheimers #moretime #accessnow #ENDALZ 💜

[Kate Kriner @k8kriner]

Thank you Kelsey, @RepMcClintock’s office, for your time today discussing our #Alzheimers’ priorities. #ENDALZ #AccessNow #moretime

[Elizabeth Edgerly @eedgerly]

Congrats to Jay R. For winning advocate of the year. After being diagnosed with young onset AD, Jay set about working to reduce stigma by telling his story, raising $ (Over $150k!) and advocating for CMS coverage of Alzheimer’s drugs. #endalz #Alzheimers #moretime